NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Structured Abstract
Objective:
To review the benefits and harms of vitamin and mineral supplementation in healthy adults to prevent cardiovascular disease (CVD) and cancer.
Data Sources:
MEDLINE, PubMed (publisher-supplied records only), the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews, and Embase, between January 2013 and February 1, 2022. Additionally, we evaluated all studies included in the prior USPSTF review for inclusion in the current review.
Study Selection:
We reviewed 17,459 unique citations and 379 full-text articles against a priori inclusion criteria. We included English-language randomized clinical trials (RCTs) of vitamin or mineral use among persons without CVD or cancer reporting all-cause mortality, CVD, cancer, or adverse outcomes as well as observational cohort studies examining serious harms of supplement use. Critical appraisal was completed independently by two investigators. Data were extracted from studies by one reviewer and checked by a second.
Data Analysis:
We conducted quantitative pooling when at least three studies of the same supplement reported the same outcome. Because most outcomes occurred in less than 10 percent of the study sample, we typically used methods appropriate for rare events, including a fixed effects Mantel-Haenszel model or a random effects restricted maximum likelihood model using Peto odds ratio. Stratified or subgroup analyses and meta-regression were used to explore effect modification for trials of vitamin D, which had the largest body of evidence.
Results:
A total of 84 studies (n=739,803) were included. Pooled effects indicated that multivitamin use may be associated with a reduced risk of incidence of any cancer (OR, 0.93 [95 % CI, 0.87 to 0.99]; 4 RCTs; n=48,859; I2=0%; range in absolute risk difference among adequately powered trials, −0.2% to −1.2%) and lung cancer (OR, 0.75 [95% CI, 0.58 to 0.95]; 2 RCTs, n=36,052; I2=30%; absolute risk difference, 0.2%). However, the evidence for multivitamins had important limitations, including only three adequately powered trials, one with a median of only 3.6 years of multivitamin use and another that was limited to antioxidants. Pooling of studies of vitamin D with or without calcium showed no association with all-cause mortality (OR, 0.96 [95% CI, 0.91 to 1.02]; 27 RCTs [n=117,082]; I2=0%), CVD (e.g., composite CVD events: OR, 1.00 [0.95 to 1.05]; 7 RCTs [n=74,925]; I2=0%), or cancer outcomes (e.g. any cancer incidence: OR, 0.98 [0.92 to 1.03]; 19 RCTs [n=86,899]; I2=0%).
Beta-carotene, with or without vitamin A, was associated with an increased risk of cardiovascular mortality (OR 1.10 [95% CI, 1.02 to 1.19]; 5 RCTs [n=94,506]; I2=0%; range in absolute risk difference −0.8% to 0.8%), and lung cancer (OR 1.20 [95% CI, 1.01 to 1.42]; 4 RCTs [n=94,830]; I2=38.8%; range in absolute risk difference −0.1% to 0.6%). In addition, we found less robust evidence that folic acid was associated with an increased risk of cancer incidence.
We found clear evidence that vitamin E (with or without vitamin C or selenium) offers no benefit for all-cause mortality (OR, 1.02 [95% CI, 0.97 to 1.07]; 9 RCTs [n=107,772]; I2=0%), CVD events (OR, 0.96 [95% CI, 0.90 to 1.04]; 4 RCTs [n=62,136]; I2=0%), and cancer (OR, 1.02 [95% CI, 0.98 to 1.08]; 5 RCTs [n=76,777]; I2=0%), and more equivocal evidence that multivitamins (antioxidant-focused or broad spectrum), vitamin A (without beta-carotene), vitamin C, calcium (without vitamin D), and selenium also had no impact on all-cause mortality, CVD, and cancer.
There was also weak evidence that supplements increased the risk of some other serious harms, such as hip fracture (vitamin A), hemorrhagic stroke (vitamin E), and kidney stones (vitamin C, calcium). Several supplements were associated with an increased risk of some minor and reversible adverse outcomes, such as skin yellowing (beta-carotene) and gastrointestinal symptoms (calcium).
Limitations:
Some studies lacked full outcome ascertainment or had insufficient followup or power for the main review outcomes; varied background interventions (primarily due to factorial designs) may cloud supplement effects; people of color were minimally represented. Most supplements had too few studies to explore effect modification.
Conclusions:
Vitamin and mineral supplementation provides little to no benefit in preventing cancer, CVD, and death, with the exception of a possible small benefit for cancer incidence with multivitamin use, where lung cancer showed the largest benefit. Beta-carotene is associated with increased risk of lung cancer and other harmful outcomes in persons at high risk of lung cancer. Data were absent or insufficient to draw conclusions for any of the B vitamins, iron, zinc, or magnesium.
Contents
- Acknowledgments
- Chapter 1. Introduction
- Chapter 2. Methods
- Chapter 3. Results
- Description of Included Studies
- KQ1 and KQ2. What Is the Efficacy of Multivitamin Supplementation for Reducing CVD, Cancer, and Mortality in the General Adult Population? What Are the Harms of Multivitamin Supplementation in the General Adult Population?
- KQ3 and KQ4. What Is the Efficacy of Supplementation With Single Nutrients or Functionally Related Nutrient Pairs for Reducing CVD, Cancer, and Mortality in the General Adult Population? What Are the Harms of Supplementation With Single Nutrients in the General Adult Population?
- Chapter 4. Discussion
- References
- Appendixes
Suggested citation:
O’Connor EA, Evans CV, Ivlev I, Rushkin MC, Thomas RG, Martin A, Lin JS. Vitamin, Mineral, and Multivitamin Supplementation for the Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 209. AHRQ Publication No. 21-05278-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2022.
This report is based on research conducted by the Kaiser Permanente Research Affiliates Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. HHSA-290-2015-00007-I, Task Order No. 75Q80118F32006). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
The information in this report is intended to help healthcare decision makers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of healthcare services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information (i.e., in the context of available resources and circumstances presented by individual patients).
This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
- NLM CatalogRelated NLM Catalog Entries
- Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.[JAMA. 2022]Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.O'Connor EA, Evans CV, Ivlev I, Rushkin MC, Thomas RG, Martin A, Lin JS. JAMA. 2022 Jun 21; 327(23):2334-2347.
- Review Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Evidence Update for the U.S. Preventive Services Task Force[ 2022]Review Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Evidence Update for the U.S. Preventive Services Task ForceGuirguis-Blake JM, Evans CV, Perdue LA, Bean SI, Senger CA. 2022 Apr
- Review Interventions to Prevent Falls in Community-Dwelling Older Adults: A Systematic Review for the U.S. Preventive Services Task Force[ 2018]Review Interventions to Prevent Falls in Community-Dwelling Older Adults: A Systematic Review for the U.S. Preventive Services Task ForceGuirguis-Blake JM, Michael YL, Perdue LA, Coppola EL, Beil TL, Thompson JH. 2018 Apr
- Review Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force[ 2015]Review Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task ForceWhitlock EP, Williams SB, Burda BU, Feightner A, Beil T. 2015 Sep
- Review Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force[ 2017]Review Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task ForcePatnode CD, Evans CV, Senger CA, Redmond N, Lin JS. 2017 Jul
- Vitamin, Mineral, and Multivitamin Supplementation for the Primary Prevention of...Vitamin, Mineral, and Multivitamin Supplementation for the Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force
- SRS7854140 (1)SRA
- Cocculus trilobus 26S ribosomal RNA gene, partial sequenceCocculus trilobus 26S ribosomal RNA gene, partial sequencegi|229464211|gb|FJ626466.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...